From the Lupus and Arthritis Research Unit, Rayne Institute (M.A.K., M.J.C., F.M., G.R.V.H.); the Department of Public Health Medicine, United Medical and Dental Schools of Guy's and St. Thomas's Hospitals (N.A.T.); and the Hemophilia Center, St. Thomas's Hospital (B.J.H.) — all in London.
Address reprint requests to Dr. Khamashta at the Lupus Research Unit, Rayne Institute, St. Thomas's Hospital, London SE1 7EH, United Kingdom.
Thrombosis in the Antiphospholipid-Antibody Syndrome
Violi F., Ferro D., Valesini G., Rapaport S. I., Le D. T., Slivka A., Walz E., Cole A. J., Nasr S. Z., Parke A. L., Khamashta M. A., Taub N. A., Hunt B. J., Lockshin M. D.
Extract |
Full Text
N Engl J Med 1995;
333:665-667, Sep 7, 1995.
Correspondence
Anticoagulation for Venous Thromboembolism
Bucciarelli P., Alatri A., Moia M., Khamashta M. A., Williams F. M.K., Hunt B. J., Kearon C., Ginsberg J. S., Gent M.
Extract |
Full Text
N Engl J Med 1999;
341:539-540, Aug 12, 1999.
Correspondence
This article has been cited by other articles:
Greco, T. P., Conti-Kelly, A. M., Greco, T. Jr, Doyle, R., Matsuura, E., Anthony, J. R., Lopez, L. R.
(2009). Newer Antiphospholipid Antibodies Predict Adverse Outcomes in Patients With Acute Coronary Syndrome. Am J Clin Pathol
132: 613-620
[Abstract][Full Text]
Giannakopoulos, B., Krilis, S. A.
(2009). How I treat the antiphospholipid syndrome. Blood
114: 2020-2030
[Abstract][Full Text]
Cervera, R, Boffa, M-C, Khamashta, M., Hughes, G.
(2009). The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe. Lupus
18: 889-893
[Abstract]
Cervera, R, Khamashta, M A, Shoenfeld, Y, Camps, M T, Jacobsen, S, Kiss, E, Zeher, M M, Tincani, A, Kontopoulou-Griva, I, Galeazzi, M, Bellisai, F, Meroni, P L, Derksen, R H W M, de Groot, P G, Gromnica-Ihle, E, Baleva, M, Mosca, M, Bombardieri, S, Houssiau, F, Gris, J-C, Quere, I, Hachulla, E, Vasconcelos, C, Roch, B, Fernandez-Nebro, A, Piette, J-C, Espinosa, G, Bucciarelli, S, Pisoni, C N, Bertolaccini, M L, Boffa, M-C, Hughes, G R V, on behalf of the Euro-Phospholipid Project Group (,
(2009). Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis
68: 1428-1432
[Abstract][Full Text]
Tan, B., Thong, B., Shivananda, S, Han, W., Chng, H.
(2009). Clinical manifestations and outcomes of antithrombotic treatment of the Tan Tock Seng Hospital Singapore antiphospholipid syndrome cohort. Lupus
18: 752-758
[Abstract]
Cianci, R., Gigante, A., Barbano, B., Zaccaria, A., Polidori, L., Borghesi, F., Gasperini, L., Di Donato, D., Amoroso, A.
(2009). Multiple steno-obstructive vascular lesions and femoral superficial artery dissection in a young Caucasian male with antiphospholipid syndrome. BMJ Case Reports
2009: bcr1220081342-bcr1220081342
[Abstract][Full Text]
Zhu, T., Martinez, I., Emmerich, J.
(2009). Venous Thromboembolism: Risk Factors for Recurrence. Arterioscler. Thromb. Vasc. Bio.
29: 298-310
[Abstract][Full Text]
Farmer-Boatwright, M. K., Roubey, R. A.S.
(2009). Venous Thrombosis in the Antiphospholipid Syndrome. Arterioscler. Thromb. Vasc. Bio.
29: 321-325
[Abstract][Full Text]
Matsuura, E, Lopez, L.
(2008). Autoimmune-mediated atherothrombosis. Lupus
17: 879-888
[Abstract]
Ansell, J., Hirsh, J., Hylek, E., Jacobson, A., Crowther, M., Palareti, G.
(2008). Pharmacology and Management of the Vitamin K Antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest
133: 160S-198S
[Abstract][Full Text]
Horner, K. E., Phillips, B. B., Newkirk, E., McDanel, D. L., Kaboli, P.
(2008). Evaluation of anticoagulation in patients with antiphospholipid syndrome. Am J Health Syst Pharm
65: 964-967
[Abstract][Full Text]
Lockshin, M., Derksen, R.
(2008). New developments in lupus-associated antiphospholipid syndrome. Lupus
17: 443-446
[Abstract]
Davie, C A, O'Brien, P
(2008). Stroke and pregnancy. J. Neurol. Neurosurg. Psychiatry
79: 240-245
[Abstract][Full Text]
Gorki, H., Malinovski, V., Stanbridge, R. D.L.
(2008). The antiphospholipid syndrome and heart valve surgery. Eur. J. Cardiothorac. Surg.
33: 168-181
[Abstract][Full Text]
Bertsias, G, Ioannidis, J P A, Boletis, J, Bombardieri, S, Cervera, R, Dostal, C, Font, J, Gilboe, I M, Houssiau, F, Huizinga, T, Isenberg, D, Kallenberg, C G M, Khamashta, M, Piette, J C, Schneider, M, Smolen, J, Sturfelt, G, Tincani, A, van Vollenhoven, R, Gordon, C, Boumpas, D T
(2008). EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis
67: 195-205
[Abstract][Full Text]
Swigris, J. J., Fischer, A., Gilles, J., Meehan, R. T., Brown, K. K.
(2008). Pulmonary and Thrombotic Manifestations of Systemic Lupus Erythematosus. Chest
133: 271-280
[Abstract][Full Text]
Goldenberg, N. A.
(2008). Thrombophilia States and Markers of Coagulation Activation in the Prediction of Pediatric Venous Thromboembolic Outcomes: A Comparative Analysis with Respect to Adult Evidence. ASH Education Book
2008: 236-244
[Abstract][Full Text]
Bounameaux, H., Perrier, A.
(2008). Duration of Anticoagulation Therapy for Venous Thromboembolism. ASH Education Book
2008: 252-258
[Abstract][Full Text]
Avcin, T., Silverman, E.
(2007). Review: Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome. Lupus
16: 627-633
[Abstract]
Garcia-Carrasco, M., Galarza, C., Gomez-Ponce, M., Cervera, R., Rojas-Rodriguez, J., Espinosa, G., Bucciarelli, S., Gomez-Puerta, J.A., Bove, A., Escarcega, R.O., Font, J.
(2007). Antiphospholipid syndrome in Latin American patients: clinical and immunologic characteristics and comparison with European patients. Lupus
16: 366-373
[Abstract]
Krause, I, Leibovici, L, Blank, M, Shoenfeld, Y
(2007). Clusters of disease manifestations in patients with antiphospholipid syndrome demonstrated by factor analysis. Lupus
16: 176-180
[Abstract]
Rand, J. H.
(2007). The Antiphospholipid Syndrome. ASH Education Book
2007: 136-142
[Abstract][Full Text]
Szekanecz, Z, Shoenfeld, Y
(2006). Lupus and cardiovascular disease: the facts. Lupus
15: 3-10
[Abstract]
Scarvelis, D., Wells, P. S.
(2006). Diagnosis and treatment of deep-vein thrombosis.. CMAJ
175: 1087-1092
[Abstract][Full Text]
Tincani, A., Rebaioli, C. B., Taglietti, M., Shoenfeld, Y.
(2006). Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus. Rheumatology (Oxford)
45: iv8-iv13
[Abstract][Full Text]
Giles, I., Lambrianides, N., Pattni, N., Faulkes, D., Latchman, D., Chen, P., Pierangeli, S., Isenberg, D., Rahman, A.
(2006). Arginine Residues Are Important in Determining the Binding of Human Monoclonal Antiphospholipid Antibodies to Clinically Relevant Antigens. J. Immunol.
177: 1729-1736
[Abstract][Full Text]
Wahl, D., Regnault, V.
(2006). Treatment of antiphospholipid antibody syndrome.. JAMA
296: 42-43
[Full Text]
Ben-Ami, D, Bar-Meir, E, Shoenfeld, Y
(2006). Stenosis in Antiphospholipid Syndrome: A New Finding with Clinical Implications. Lupus
15: 466-472
[Abstract]
Ostertag, M V., Liu, X, Henderson, V, Pierangeli, S S
(2006). A peptide that mimics the Vth region of {beta}2glycoprotein I reverses antiphospholipid-mediated thrombosis in mice. Lupus
15: 358-365
[Abstract]
Ingegnoli, F, Soldi, A, Meani, L, Zeni, S, Fantini, F
(2006). Primary antiphospholipid syndrome associated with small aorta syndrome: a case report. Lupus
15: 236-239
[Abstract]
Paran, D, Chapman, J, Korczyn, A D, Elkayam, O, Hilkevich, O, Groozman, G B, Levartovsky, D, Litinsky, I, Caspi, D, Segev, Y, Drory, V E
(2006). Evoked potential studies in the antiphospholipid syndrome: differential diagnosis from multiple sclerosis. Ann Rheum Dis
65: 525-528
[Abstract][Full Text]
Lopez-Pedrera, C., Buendia, P, Aguirre, M A, Velasco, F, Cuadrado, M J
(2006). Antiphospholipid syndrome and tissue factor: a thrombotic couple. Lupus
15: 161-166
[Abstract]
Bertolaccini, M L, Khamashta, M A
(2006). Laboratory diagnosis and management challenges in the antiphospholipid syndrome. Lupus
15: 172-178
[Abstract]
Lim, W., Crowther, M. A., Eikelboom, J. W.
(2006). Management of Antiphospholipid Antibody Syndrome: A Systematic Review. JAMA
295: 1050-1057
[Abstract][Full Text]
Castro, I, Rios, J J, Iniesta, N, Perez, I, Robles, A, Gil, A
(2005). Letter to the Editor. Lupus
14: 979-980
Koutoulidis, V, Chatziioannou, A, Kostopoulos, C, Kontogiannis, S, Skiadas, V, Mourikis, D, Vlahos, L
(2005). Primary antiphospholipid syndrome: a unique presentation with multiple visceral aneurysms. Ann Rheum Dis
64: 1793-1794
[Full Text]
Navarrete, N, Macias, P, Jaen, F, Hidalgo, C, Caliz, R, Jimenez-Alonso, J
(2005). Two cases of catastrophic antiphospholipid syndrome. Lupus
14: 907-909
[Abstract]
Bertolaccini, M L, Gomez, S, Pareja, J F P, Theodoridou, A, Sanna, G, Hughes, G R V, Khamashta, M A
(2005). Antiphospholipid antibody tests: spreading the net. Ann Rheum Dis
64: 1639-1643
[Abstract][Full Text]
Statkute, L., Traynor, A., Oyama, Y., Yaung, K., Verda, L., Krosnjar, N., Burt, R. K.
(2005). Antiphospholipid syndrome in patients with systemic lupus erythematosus treated by autologous hematopoietic stem cell transplantation. Blood
106: 2700-2709
[Abstract][Full Text]
Matsuura, E, Kobayashi, K, Inoue, K, Lopez, L R, Shoenfeld, Y
(2005). Oxidized LDL/{beta}2-glycoprotein I complexes: new aspects in atherosclerosis. Lupus
14: 736-741
[Abstract]
Ruiz-Irastorza, G., Khamashta, M. A.
(2005). Stroke and antiphospholipid syndrome: the treatment debate. Rheumatology (Oxford)
44: 971-974
[Abstract][Full Text]
Abdullah, B J J, Mohammad, N, Sangkar, J V, Abd Aziz, Y F, Gan, G G, Goh, K Y, Benedict, I
(2005). Incidence of upper limb venous thrombosis associated with peripherally inserted central catheters (PICC). Br. J. Radiol.
78: 596-600
[Abstract][Full Text]
Turiel, M., Sarzi-Puttini, P., Peretti, R., Rossi, E., Atzeni, F., Parsons, W., Doria, A.
(2005). Thrombotic Risk Factors In Primary Antiphospholipid Syndrome: A 5-Year Prospective Study. Stroke
36: 1490-1494
[Abstract][Full Text]
Letang, E, Rodriguez-Carballeira, M, Muchart, J, Torres, J, de Echaguen, A O., Garau, J
(2005). Letter to the Editor. Lupus
14: 336-337
Ferreira, S., D'Cruz, D. P., Hughes, G. R. V.
(2005). Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand?. Rheumatology (Oxford)
44: 434-442
[Abstract][Full Text]
Stammers, A. H, Dorion, R P., Trowbridge, C., Yen, B., Klayman, M., Murdock, J. D, Woods, E., Gilbert, C.
(2005). Coagulation management of a patient with factor V Leiden mutation, lupus anticoagulant, and activated protein C resistance: a case report. Perfusion
20: 115-120
[Abstract]
Nojima, J., Kuratsune, H., Suehisa, E., Iwatani, Y., Kanakura, Y.
(2005). Acquired Activated Protein C Resistance Associated with IgG Antibodies against {beta}2-Glycoprotein I and Prothrombin as a Strong Risk Factor for Venous Thromboembolism. Clin. Chem.
51: 545-552
[Abstract][Full Text]
Sangle, S. R., D'Cruz, D. P., Abbs, I. C., Khamashta, M. A., Hughes, G. R. V.
(2005). Renal artery stenosis in hypertensive patients with antiphospholipid (Hughes) syndrome: outcome following anticoagulation. Rheumatology (Oxford)
44: 372-377
[Abstract][Full Text]
Ortel, T. L.
(2005). Thrombosis and the Antiphospholipid Syndrome. ASH Education Book
2005: 462-468
[Abstract][Full Text]
Wittkowsky, A. K.
(2004). Anticoagulation in Hypercoagulable Conditions: Special Considerations in the Treatment and Prevention of Venous Thromboembolism. Journal of Pharmacy Practice
17: 308-316
[Abstract]
Parke, A
(2004). Short and long-term maternal outcomes in patients with phospholipid antibodies. Lupus
13: 703-704
[Abstract]
Ansell, J., Hirsh, J., Poller, L., Bussey, H., Jacobson, A., Hylek, E.
(2004). The Pharmacology and Management of the Vitamin K Antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest
126: 204S-233S
[Abstract][Full Text]
Buller, H. R., Agnelli, G., Hull, R. D., Hyers, T. M., Prins, M. H., Raskob, G. E.
(2004). Antithrombotic Therapy for Venous Thromboembolic Disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest
126: 401S-428S
[Abstract][Full Text]
Greaves, M.
(2004). Masterclass series in peripheral arterial disease: Acquired thrombophilia. Vasc Med
9: 215-218
Boura, P., Tselios, K., Skendros, P., Kountouras, J.
(2004). Antiphospholipid Syndrome in Greece: Clinical and Immunological Study and Review of the Literature. ANGIOLOGY
55: 421-430
[Abstract]
Kyrle, P. A., Minar, E., Bialonczyk, C., Hirschl, M., Weltermann, A., Eichinger, S.
(2004). The Risk of Recurrent Venous Thromboembolism in Men and Women. NEJM
350: 2558-2563
[Abstract][Full Text]
Yaqub, S., Moder, K. G., Lacy, M. Q.
(2004). Severe, Reversible Pulmonary Hypertension in a Patient With Monoclonal Gammopathy and Features of Dermatomyositis. Mayo Clin Proc.
79: 687-689
[Abstract]
Ozturk, M. A., Haznedaroglu, I. C., Turgut, M., Goker, H.
(2004). Current Debates in Antiphospholipid Syndrome: The Acquired Antibody-Mediated Thrombophilia. CLIN APPL THROMB HEMOST
10: 89-126
[Abstract]
O'Rourke, F., Dean, N., Akhtar, N., Shuaib, A.
(2004). Current and future concepts in stroke prevention. CMAJ
170: 1123-1133
[Abstract][Full Text]
Caprini, J. A., Glase, C. J., Anderson, C. B., Hathaway, K.
(2004). Laboratory Markers in the Diagnosis of Venous Thromboembolism. Circulation
109: I-4-I-8
[Abstract][Full Text]
Spencer, H L, Kamisawa, T, Funata, N, Okamoto, A
(2004). Primary antiphospholipid syndrome as a new cause of autoimmune pancreatitis * Author's reply. Gut
53: 468-468
[Full Text]
APASS Investigators,
(2004). Antiphospholipid Antibodies and Subsequent Thrombo-occlusive Events in Patients With Ischemic Stroke. JAMA
291: 576-584
[Abstract][Full Text]
Yagi, K, Kawano, M, Haraki, T, Higashikata, T, Ueda, K, Okada, T, Koni, I, Mabuchi, H
(2004). Long-term efficacy of immunoadsorbent plasmapheresis in a patient with Budd-Chiari syndrome due to antiphospholipid syndrome: case report with nine-year follow-up. Lupus
13: 135-138
[Abstract]
Ruiz-Irastorza, G., Egurbide, M.-V., Ugalde, J., Aguirre, C.
(2004). High Impact of Antiphospholipid Syndrome on Irreversible Organ Damage and Survival of Patients With Systemic Lupus Erythematosus. Arch Intern Med
164: 77-82
[Abstract][Full Text]
Wajed, J., Ahmad, Y., Durrington, P. N., Bruce, I. N.
(2004). Prevention of cardiovascular disease in systemic lupus erythematosus--proposed guidelines for risk factor management. Rheumatology (Oxford)
43: 7-12
[Full Text]
Katzav, A, Chapman, J, Shoenfeld, Y
(2003). CNS dysfunction in the antiphospholipid syndrome. Lupus
12: 903-907
[Abstract]
Connor, P, Hunt, B J
(2003). Cerebral haemostasis and antiphospholipid antibodies. Lupus
12: 929-934
[Abstract]
Sanna, G, Bertolaccini, M L, Mathieu, A
(2003). Central nervous system lupus: a clinical approach to therapy. Lupus
12: 935-942
[Abstract]
Campos, L M., Kiss, M H, D'Amico, E A, Silva, C A A.
(2003). Antiphospholipid antibodies and antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus. Lupus
12: 820-826
[Abstract]
Crowther, M. A., Ginsberg, J. S., Julian, J., Denburg, J., Hirsh, J., Douketis, J., Laskin, C., Fortin, P., Anderson, D., Kearon, C., Clarke, A., Geerts, W., Forgie, M., Green, D., Costantini, L., Yacura, W., Wilson, S., Gent, M., Kovacs, M. J.
(2003). A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome. NEJM
349: 1133-1138
[Abstract][Full Text]
Lockshin, M. D., Erkan, D.
(2003). Treatment of the Antiphospholipid Syndrome. NEJM
349: 1177-1179
[Full Text]
Tektonidou, M. G, Vlachoyiannopoulos, P. G
(2003). Letter to the Editor. Lupus
12: 723-724
Schulman, S.
(2003). Care of Patients Receiving Long-Term Anticoagulant Therapy. NEJM
349: 675-683
[Full Text]
Derksen, R.H.W.M., de Groot, P.G., Kappelle, L.J.
(2003). Low dose aspirin after ischemic stroke associated with antiphospholipid syndrome. Neurology
61: 111-114
[Abstract][Full Text]
Shoenfeld, Y
(2003). Systemic antiphospholipid syndrome. Lupus
12: 497-498
[Abstract]
Alarcon-Segovia, D, Boffa, M C, Branch, W, Cervera, R, Gharavi, A, Khamashta, M, Shoenfeld, Y, Wilson, W, Roubey, R
(2003). Prophylaxis of the antiphospholipid syndrome: a consensus report. Lupus
12: 499-503
[Abstract]
Meroni, P L, Moia, M, Derksen, R H., Tincani, A, McIntyre, J A, Arnout, J M., Koike, T, Piette, J-C, Khamashta, M A, Shoenfeld, Y
(2003). Venous thromboembolism in the antiphospholipid syndrome: management guidelines for secondary prophylaxis. Lupus
12: 504-507
[Abstract]
Brey, R L, Chapman, J, Levine, S R, Ruiz-Irastorza, G, Derksen, R H., Khamashta, M, Shoenfeld, Y
(2003). Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002. Lupus
12: 508-513
[Abstract]
Hanly, J. G.
(2003). Antiphospholipid syndrome: an overview. CMAJ
168: 1675-1682
[Abstract][Full Text]
Hyers, T. M.
(2003). Duration of Anticoagulation in Venous Thromboembolism. Arch Intern Med
163: 1265-1266
[Full Text]
van Dongen, C. J. J., Vink, R., Hutten, B. A., Buller, H. R., Prins, M. H.
(2003). The Incidence of Recurrent Venous Thromboembolism After Treatment With Vitamin K Antagonists in Relation to Time Since First Event: A Meta-analysis. Arch Intern Med
163: 1285-1293
[Abstract][Full Text]
Erkan, D, Asherson, R A, Espinosa, G, Cervera, R, Font, J, Piette, J-C, Lockshin, M D
(2003). Long term outcome of catastrophic antiphospholipid syndrome survivors. Ann Rheum Dis
62: 530-533
[Abstract][Full Text]
Ramos-Casals, M, Garcia-Carrasco, M, Brito, M P, Lopez-Soto, A, Font, J
(2003). Autoimmunity and geriatrics: clinical significance of autoimmune manifestations in the elderly. Lupus
12: 341-355
[Abstract]
Streiff, M. B.
(2003). Vena Caval Filters: A Review for Intensive Care Specialists. J Intensive Care Med
18: 59-79
[Abstract]
Galli, M., Luciani, D., Bertolini, G., Barbui, T.
(2003). Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood
101: 1827-1832
[Abstract][Full Text]
Deitcher, S. R, Gomes, M. P.
(2003). Hypercoagulable state testing and malignancy screening following venous thromboembolic events. Vasc Med
8: 33-46
[Abstract]
Sanna, G., Bertolaccini, M. L., Cuadrado, M. J., Khamashta, M. A., Hughes, G. R. V.
(2003). Central nervous system involvement in the antiphospholipid (Hughes) syndrome. Rheumatology (Oxford)
42: 200-213
[Abstract][Full Text]
Hughes, G R V
(2003). Migraine, memory loss, and "multiple sclerosis ". Neurological features of the antiphospholipid (Hughes') syndrome. Postgrad. Med. J.
79: 81-83
[Abstract][Full Text]
Sanni, G., Khamashta, M. A
(2003). Low-dose pulse cyclophosphamide in the treatment of neuropsychiatric lupus. Lupus
12: 1-2
Warkentin, T. E., Aird, W. C., Rand, J. H.
(2003). Platelet-Endothelial Interactions: Sepsis, HIT, and Antiphospholipid Syndrome. ASH Education Book
2003: 497-519
[Abstract][Full Text]
Prandoni, P., Lensing, A. W.A., Prins, M. H., Bernardi, E., Marchiori, A., Bagatella, P., Frulla, M., Mosena, L., Tormene, D., Piccioli, A., Simioni, P., Girolami, A.
(2002). Residual Venous Thrombosis as a Predictive Factor of Recurrent Venous Thromboembolism. ANN INTERN MED
137: 955-960
[Abstract][Full Text]
Prandoni, P., Lensing, A. W. A., Piccioli, A., Bernardi, E., Simioni, P., Girolami, B., Marchiori, A., Sabbion, P., Prins, M. H., Noventa, F., Girolami, A.
(2002). Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood
100: 3484-3488
[Abstract][Full Text]
Maslowski, L., McBane, R., Alexewicz, P., Wysokinski, W. E
(2002). Antiphospholipid antibodies in thromboangiitis obliterans. Vasc Med
7: 259-264
[Abstract]
Bick, R. L., Alfar, H., Goedecke, C.
(2002). Thrombophilic Causes of Retinal Vascular Thrombosis: Etiology and Treatment Outcomes. CLIN APPL THROMB HEMOST
8: 315-318
Joffe, H. V., Goldhaber, S. Z.
(2002). Upper-Extremity Deep Vein Thrombosis. Circulation
106: 1874-1880
[Full Text]
Bloom, B. J., Smith, R. N.
(2002). Case 29-2002 - A 17-Year-Old Boy with Acute Mitral Regurgitation and Pulmonary Edema. NEJM
347: 921-928
[Full Text]
Goichot, B., Perrin, A.-E., Thomas, R. H.
(2002). Hypercoagulable Disorders. Arch Intern Med
162: 1785-1787
[Full Text]
Moll, S., Ortel, T. L.
(2002). Antiphospholipid Antibodies. Arch Intern Med
162: 1783-1784
[Full Text]
Alfayate, J. M., Acin, F., Bueno, A., March, J. R., Lopez-Quintana, A., Cancer, S., Ros, R.
(2002). Aortoiliac Thrombosis in Antiphospholipid Syndrome: Case Report and Literature Review. VASC ENDOVASCULAR SURG
36: 311-315
[Abstract]
Previous
